CDKN2A and neoplasm: Of note, the expression of some p16INK4-regulators (Ets1/2, YB1, AP-1 proteins), which are downstream targets of the Ras pathway, is significantly increased (Cromer dataset—Table 3), suggesting that dysregulation of pRb and Ras pathways might work in concert to sustain tumor progression in these samples.